| Evaluation of Current Status of Urine and Serum Biomarkers in the Diagnosis and Follow-up of Bladder Cancer: Review | Mehmet YILDIZHAN,Hakan GEMALMAZ | 127–134 |
| ABO Blood Types and Risk of Testicular Cancer in Turkish Population: Preliminary Results | Şebnem İZMİR GÜNER,Ekrem GÜNER | 135–137 |
| Researching Predictive Value of White Blood Cell Rates for Diagnosis of Prostate Cancer in the Patients Undergoing Prostate Biopsy: A Pilot Study | Kaan KARAMIK,Yasin AKTAŞ,Selim TAŞ,Hakan ANIL,Ekrem İSLAMOĞLU,Mutlu ATEŞ,Murat SAVAŞ | 138–142 |
| A Retrospective Study of Patients with Recurrent or Refractory Testicular Germ Cell Tumors Treated with High-dose Chemotherapy and Autologous Peripheral-blood Stem-cell Transplantation Single-center Experience | Şebnem İZMİR GÜNER,Ekrem GÜNER | 143–148 |
| Prognostic Value of the mRNA Expression of Members of the Toll-like Receptor Family in Clear Cell Renal Cell Carcinoma | Seda SABAH ÖZCAN,Payam HACISALİHOĞLU,Serdar YANIK | 149–153 |
| Comparison of Robotic and Laparoscopic Partial Nephrectomy in Robotic Surgery Era | Ekrem GÜNER,Selçuk ŞAHİN | 154–157 |
| Challenges in Differential Diagnosis: A Case Series of Four Adult Patients with Renal Leiomyoma | Mehmet Necmettin MERCİMEK,Ender ÖZDEN,Yarkın Kamil YAKUPOĞLU | 158–161 |